BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34942295)

  • 21. Ibrutinib-induced pyoderma gangrenosum.
    Sławińska M; Barańska-Rybak W; Sobjanek M; Wilkowska A; Mital A; Nowicki R
    Pol Arch Med Wewn; 2016 Sep; 126(9):710-711. PubMed ID: 27698335
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine.
    Graziano F; Macaluso FS; Cassata N; Citrano M; Orlando A
    Inflamm Bowel Dis; 2021 Aug; 27(9):e110-e111. PubMed ID: 34003258
    [No Abstract]   [Full Text] [Related]  

  • 23. Pyoderma gangrenosum associated with dulaglutide therapy.
    Hamann CR; Chung C; Kaffenberger BH
    Int J Dermatol; 2019 Oct; 58(10):1202-1204. PubMed ID: 30345551
    [No Abstract]   [Full Text] [Related]  

  • 24. Pyoderma gangrenosum with the use of sunitinib.
    Nadauld LD; Miller MB; Srinivas S
    J Clin Oncol; 2011 Apr; 29(10):e266-7. PubMed ID: 21220606
    [No Abstract]   [Full Text] [Related]  

  • 25. [A case of pyoderma gangrenosum associated to bevacizumab, angiogenesis role in its etiology].
    Maray-Mateos I; Álvarez-Asteinza C; Carbajales-Álvarez M; Lozano-Blázquez A
    Farm Hosp; 2021 Sep; 45(6):340-341. PubMed ID: 34806575
    [No Abstract]   [Full Text] [Related]  

  • 26. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
    Brenner M; Ruzicka T; Plewig G; Thomas P; Herzer P
    Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin.
    Sinagra E; Orlando A; Renna S; Maida M; Cottone M
    Inflamm Bowel Dis; 2012 Aug; 18(8):E1594-5. PubMed ID: 22038892
    [No Abstract]   [Full Text] [Related]  

  • 28. A case of pyoderma gangrenosum induced by insulin.
    Noronha M; Arora S; Pai K; Sathish Pai B; Jindal A
    Int Wound J; 2019 Oct; 16(5):1239-1242. PubMed ID: 31353778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When is recalcitrant pyoderma gangrenosum truly recalcitrant?
    Barnabé C; Hurst L; Alowami S
    J Cutan Med Surg; 2003; 7(5):387-9. PubMed ID: 14758523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gentian violet for pyoderma gangrenosum: a retrospective chart review.
    Stiff KM; Glines KR; Muse ME; Cline A; Feldman SR; Jorizzo JL; Huang WW
    Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyoderma gangrenosum in a patient with essential thrombocythemia.
    King KW; Murray A
    J Cutan Med Surg; 2000 Apr; 4(2):107-9. PubMed ID: 11179935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
    Ueharaguchi Y; Kabashima K; Sasahashi M; Matsuda A; Matubara K; Matsui M
    Int J Dermatol; 2013 May; 52(5):634-6. PubMed ID: 23590380
    [No Abstract]   [Full Text] [Related]  

  • 33. First case of lenvatinib-induced pyoderma gangrenosum: Possible management with dose reduction.
    Miyagawa A; Adachi T; Takamiyagi S; Arakawa H; Matsushita M; Inazumi T
    J Dermatol; 2021 May; 48(5):e221-e222. PubMed ID: 33651422
    [No Abstract]   [Full Text] [Related]  

  • 34. Pyoderma gangrenosum: a clinical manifestation of difficult diagnosis.
    Santos M; Talhari C; Rabelo RF; Schettini AP; Chirano CA; Talhari S
    An Bras Dermatol; 2011; 86(1):153-6. PubMed ID: 21437541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recalcitrant pyoderma gangrenosum treated with thalidomide.
    Federman GL; Federman DG
    Mayo Clin Proc; 2000 Aug; 75(8):842-4. PubMed ID: 10943240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone.
    Handler MZ; Hamilton H; Aires D
    J Drugs Dermatol; 2011 Sep; 10(9):1059-61. PubMed ID: 22052278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyoderma gangrenosum at multiple sites in a post-colostomy ulcerative colitis patient with chronic hepatitis B virus: A case report.
    Wang B; Liu T; Liu F; He YL
    Int Wound J; 2020 Feb; 17(1):187-190. PubMed ID: 31663272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyoderma gangrenosum; a rare complication of sclerotherapy.
    De Felice E; Allen B
    Phlebology; 2009 Oct; 24(5):213-4. PubMed ID: 19767488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyoderma gangrenosum in a caesarean wound following caesarean section with late occurrence of pyoderma gangrenosum of the breast.
    Cokan A; Dovnik A; Žebeljan I; Mujezinović F; Bujas T; Marko PB
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():343-4. PubMed ID: 27435999
    [No Abstract]   [Full Text] [Related]  

  • 40. Topical treatment with 1% sodium cromoglycate in pyoderma gangrenosum.
    Tamir A; Landau M; Brenner S
    Dermatology; 1996; 192(3):252-4. PubMed ID: 8726641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.